Trials / Sponsors / Finch Research and Development LLC.
Finch Research and Development LLC.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4) Recurrent C. Difficile Infection | Phase 3 | 2021-11-15 |
| Withdrawn | Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Sp Autism Spectrum Disorder, Autism, ASD | Phase 2 | 2020-05-01 |
| Completed | Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurr Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff | Phase 2 | 2018-05-01 |
| Completed | Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent Clostridium Difficile Infection Recurrence | Phase 2 | 2017-05-08 |